Results for tag: "Stargardt Disease Drug"

Stargardt Disease is a rare, inherited form of macular degeneration that affects the central vision of young people. It is caused by a genetic mutation that leads to the accumulation of toxic waste products in the macula, the part of the eye responsible for sharp, central vision. Treatment for Stargardt Disease is limited to supportive care, such as low vision aids and nutritional supplements. However, there is an emerging market for drugs that can slow the progression of the disease. Optical Disorders Drugs are a class of medications that are used to treat a variety of eye diseases, including Stargardt Disease. These drugs are designed to reduce the accumulation of toxic waste products in the macula, as well as to protect the macula from further damage. They may also be used to improve vision in patients with Stargardt Disease. The market for Optical Disorders Drugs is growing as more treatments become available. Companies such as Genentech, Allergan, and Novartis are leading the way in developing new drugs for Stargardt Disease and other optical disorders. These companies are investing heavily in research and development to create new treatments that can improve the quality of life for those affected by Stargardt Disease. Show Less Read more